NOVEL INFLAMMATORY RISK MARKERS INCLUDING LPPLA2 AND RISK OF CHD IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLAEMIA (FH)

Eitemau Tebyg

• NOVEL INFLAMMATORY RISK MARKERS INCLUDING LPPLA2 AND RISK OF CHD IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLAEMIA (FH)
  gan: Seed, M, et al.
  Cyhoeddwyd: (2009)
• Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia
  gan: Neil, A, et al.
  Cyhoeddwyd: (2003)
• Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia
  gan: Neil, H, et al.
  Cyhoeddwyd: (2003)
• Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia.
  gan: Neil, H, et al.
  Cyhoeddwyd: (2004)
• CURRENT STATIN TREATMENT OF PATIENTS WITH FAMILIAL HYPERCHOLESTEROLAEMIA (FH): RESULTS FROM THE ROYAL COLLEGE OF PHYSICIANS UK NATIONAL AUDIT
  gan: Seed, M, et al.
  Cyhoeddwyd: (2011)